Medi-Tech Insights Get in touch

Global Immuno-Oncology (IO) Market Size & Trends Report Segmented by Therapy Type (CAR-T Cell, Cancer Vaccines, Bispecific Antibodies, mAbs), Cancer Type (Lung, Breast, Colorectal, Melanoma), End User (Hospitals, Specialty Clinics) & Regional Forecast to 2030

Request Quote Download FREE Sample
Single User

Table of Contents

  • Introduction
    • Introduction
    • Market Scope
      • Market Definition
      • Segments Covered
      • Regional Segmentation
    • Research Timeframe
    • Currency Considered
    • Study Limitations
    • Stakeholders
    • List of Abbreviations
    • Key Conferences and Events (2025-2026)
  • Research Methodology
    • Secondary Research
    • Primary Research
    • Market Estimation
      • Bottom-Up Approach
      • Top-Down Approach
    • Market Forecasting
  • Executive Summary
    • Immuno-Oncology (IO) Market Snapshot (2025-2030)
    • Segment Overview
    • Regional Snapshot
    • Competitive Insights
  • Favourable regulatory support and approvals
  • Growing investment in cancer immunotherapy R&D
  • Expanding applications beyond traditional indications
  • Restraints
    • High treatment costs and limited reimbursement
    • Severe side effects and toxicity concerns
    • Tumor resistance and variable patient response
    • Complex manufacturing and supply chain issues
  • Opportunities
    • Expansion of combination therapies
    • Growth in biomarker-driven immunotherapies
    • Expansion into emerging markets
    • Advancements in cell-based immunotherapies
  • Key Market Trends
    • Growth in Biomarker-Driven Immunotherapies
    • Advancements in Cell-Based Immunotherapies
    • Pipeline Analysis
  • Unmet Market Needs
  • Industry Speaks
  • Global Immuno-Oncology (orecast (2023-2030), By Therapy Type, USD Million
    • Introduction
    • Immune Checkpoint Inhibitors (ICIs)
    • CAR-T Cell Therapy
    • Cancer Vaccines
    • Bispecific Antibodies
    • Monoclonal Antibodies
    • Oncolytic Viruses
    • Cytokine Therapy
    • Others
  • Global Immuno-Oncology (IO) Market Size & Forecast (2023-2030), By Cancer Type, USD Million
    • Introduction
    • Lung Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Prostate Cancer
    • Melanoma
    • Ovarian Cancer
    • Others
  • Global Immuno-Oncology (IO) Market Size & Forecast (2023-2030), By End User, USD Million
    • Introduction
    • Hospitals & Cancer Treatment Centers
    • Specialty Clinics
    • Others
  • Global Immuno-Oncamp; Forecast (2023-2030), By Region, USD Million
    • Introduction
    • North America Immuno-Oncology (IO) Market Size & Forecast (2023-2030), By Country, USD Million
      • US
        • Market Size & Forecast, By Therapy Type (USD Million)
        • Market Size & Forecast, By Cancer Type (USD Million)
        • Market Size & Forecast, By End User (USD Million)
      • Canada
        • Market Size & Forecast, By Therapy Type (USD Million)
        • Market Size & Forecast, By Cancer Type (USD Million)
        • Market Size & Forecast, By End User (USD Million)
    • Europe Immuno-Oncology (IO) Market Size & Forecast (2023-2030), By Country, USD Million
      • UK
        • Market Size & Forecast, By Therapy Type (USD Million)
        • Market Size & Forecast, By Cancer Type (USD Million)
        • Market Size & Forecast, By Cancer Type (USD Million)
        • Market Size & Forecast, By End User (USD Million)
      • France
        • Market Size & Forecast, By Therapy Type (USD Million)
        • Market Size & Forecast, By Cancer Type (USD Million)
        • Market Size & Forecast, By End User (USD Million)
      • Italy
        • Market Size & Forecast, By Therapy Type (USD Million)
        • Market Size & Forecast, By Cancer Type (USD Million)
        • Market Size & Forecast, By End User (USD Million)
      • Spain
        • Market Size & Forecast, By Therapy Type (USD Million)
        • Market Size & Forecast, By Cancer Type (USD Million)
        • Market Size & Forecast, By End User (USD Million)
      • Rest of Europe
      • Market Size & Forecast, By End User (USD Million)
  • Asia Pacific (APAC) Immuno-Oncology (IO) Market Size & Forecast (2023-2030), By Country, USD Million
    • China
      • Market Size & Forecast, By Therapy Type (USD Million)
      • Market Size & Forecast, By Cancer Type (USD Million)
      • Market Size & Forecast, By End User (USD Million)
    • Japan
      • Market Size & Forecast, By Therapy Type (USD Million)
      • Market Size & Forecast, By Cancer Type (USD Million)
      • Market Size & Forecast, By End User (USD Million)
    • India
      • Market Size & Forecast, By Therapy Type (USD Million)
      • Market Size & Forecast, By Cancer Type (USD Million)
      • Market Size & Forecast, By End User (USD Million)
    • Market Size & Forecast, By End User (USD Million)
  • Latin America (LATAM) Immuno-Oncology (IO) Market Size & Forecast (2023-2030), USD Million
    • Market Size & Forecast, By Therapy Type (USD Million)
    • Market Size & Forecast, By Cancer Type (USD Million)
    • Market Size & Forecast, By End User (USD Million)
  • Middle East & Africa (MEA) Immuno-Oncology (IO) Market Size & Forecast (2023-2030), USD Million
    • Market Size & Forecast, By Therapy Type (USD Million)
    • Market Size & Forecast, By Cancer Type (USD Million)
    • Market Size & Forecast, By End User (USD Million)
  • Competitive Landscape
    • Key Players and their Competitive Positioning
      • Key Player Comparison
      • Segment-wise Player trix
        • Dominants/Leaders
        • New Entrants
        • Emerging Players
        • Innovative Players
    • Key Strategies Assessment, By Player (2022-2025)
      • New Product Launches
      • Partnerships, Agreements, & Collaborations
      • Mergers & Acquisitions
      • Geographic Expansion
  • Company Profiles* (Business Overview, Financial Performance**, Products Offered, Recent Developments)
      • Bristol-Myers Squibb Company
      • Novartis AG
      • Hoffmann-La Roche Ltd
      • Gilead Sciences, Inc.
      • AstraZeneca
      • Sanofi
      • Moderna, Inc.
      • GSK plc.
      • AbbVie Inc.
      • Merck & Co., Inc.
      • Other Prominent Players

    Note: *Indicative list

    **For liste

    Related Reports

    View All Research Reports